ask why

Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

Infectious diseases · Clin Infect Dis · 2026-10-07

Secondary analysis of a cluster-randomised trial in 3392 South African households: only 43% initiated TB household contact tracing and 19% completed it. Greater poverty was associated with lower initiation in urban (aPR 0.903 per 10% deprivation) but not rural households.

Secondary analysisn = 3,392 households
Mohan et al. Multidimensional Poverty and Implementation Reach of Household Contact Tracing for Tuberculosis in South Africa: Analysis of a Randomized Trial
Infectious diseases · Lancet HIV · 2026-08-17

In 235 424 people with HIV starting ART in six high-burden countries, target trial emulation linked TB preventive treatment with lower tuberculosis (pooled HR 0·39) and all-cause mortality (HR 0·55, high heterogeneity, I2=96%) vs no TPT.

Meta-analysisn = 235,424
Shah et al. Programmatic effectiveness of tuberculosis preventive treatment for people with HIV in six high-tuberculosis-burden countries (PROTECT): a prospective cohort study and meta-analysis
Infectious diseases · Int J Infect Dis · 2026-07-10

Meta-analysis of 95 observational studies (63,988 hospital healthcare workers and first responders): pooled latent TB positivity was 22% by IGRA vs 38% by TST; TST, unlike IGRA, positivity was associated with higher BCG vaccination rates.

Meta-analysisn = 63,988
Alahmari et al. Interferon-gamma release assays versus tuberculin skin test for latent tuberculosis infection positivity among healthcare workers and first responders: a systematic review and meta-analysis
Infectious diseases · Clin Infect Dis · 2026-07-08

Updated systematic review and meta-analysis of 39 reports on 8 new interferon-gamma release assays for TB infection: STANDARD E TB-Feron and LIAISON XL showed accuracy and agreement similar to WHO-endorsed tests (kappa 0.80 and 0.85); certainty low.

Meta-analysisn = 39 reports
Apriani et al. Diagnostic Performance of New Commercial Interferon-Gamma Release Assays for Mycobacterium tuberculosis Infection: An Updated Systematic Review and Meta-analysis
Infectious diseases · Int J Infect Dis · 2026-06-12

Meta-analysis of 11 retrospective cohort studies (2851 patients with drug-resistant TB in Ethiopia): pooled median time to sputum culture conversion was 68.92 days (very high heterogeneity). Prior TB treatment, smear grade +2/+3, underweight and lung cavitation predicted delay.

Meta-analysisn = 2,851
Eshetu et al. Time to sputum culture conversion and its predictors among drug-resistant tuberculosis patients in Ethiopia: a systematic review and meta-analysis
Infectious diseases · Lancet Infect Dis · 2026-05-29

Phase 2b/c trial in 121 adults with drug-susceptible pulmonary TB: 4-month delamanid, bedaquiline and quabodepistat gave end-of-treatment culture conversion in 96.0% vs 100.0% with 6-month RHEZ, meeting non-inferiority (−4.0%; 12% margin). Grade ≥3 AEs 11–20% vs 5%.

RCTn = 122
Dawson et al. Efficacy and safety of a 4-month quabodepistat, delamanid, and bedaquiline regimen for drug-susceptible pulmonary tuberculosis: a multicentre, open-label, randomised, proof-of-concept, non-inferiority, phase 2b/c trial
Infectious diseases · Lancet Infect Dis · 2026-05-06

In 1172 adults with HIV admitted to 11 hospitals in Tanzania and Mozambique, expanded Xpert Ultra (sputum, stool, urine) plus urine LF-LAM testing did not raise confirmed TB starting treatment within 72 h v symptom-based testing (16.0% v 15.3%, p=0.73) or cut 8-week mortality.

RCTn = 1,172
Cossa et al. Expanding Xpert MTB/RIF Ultra and lateral flow urine lipoarabinomannan testing for diagnosis of tuberculosis among adults living with HIV admitted to hospitals in Tanzania and Mozambique (EXULTANT): a randomised controlled trial

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.